The Hormone ClinicComprehensive women's healthcare
The Injection Clinic →The Concierge Clinic →
Genitourinary syndrome of menopause (GSM)

The symptoms nobody brings up. The treatment that works.

Vaginal dryness, painful sex, burning, urinary urgency, and UTIs that keep coming back. GSM affects a large share of postmenopausal women, gets worse without treatment — and responds remarkably well to low-dose vaginal estrogen.

What's happening

GSM is structural — and progressive

The tissues of the vagina, vulva, urethra, and bladder are dense with estrogen receptors. When estrogen falls after menopause, those tissues thin, lose elasticity and blood flow, and their protective acidity shifts. The results: dryness and irritation, pain with sex, urinary urgency and burning, and a vaginal environment where UTI-causing bacteria thrive.

Unlike hot flashes, which typically fade with time, GSM does not resolve on its own — untreated, it slowly progresses. Moisturizers and lubricants help symptoms; they don't address the underlying tissue change. Low-dose vaginal estrogen does.

How vaginal estrogen works

A small dose of estrogen — as a cream, tablet, or ring — delivered directly to the tissue that needs it. Absorption into the bloodstream is minimal, which is what makes this therapy different from the systemic hormone therapy used for hot flashes: it treats locally, at a fraction of systemic exposure, and it can be used alone or alongside systemic therapy.

A note on the label: the FDA's November 2025 announcement removing boxed warnings from menopausal hormone therapy products explicitly included low-dose vaginal estrogen — a change many specialty societies had urged for years, since the old warning described risks drawn from studies of systemic therapy, not local treatment. Label nuances still differ between local and systemic products, and between estrogen-alone and combination products; we'll walk you through what applies to yours. Medication is prescribed only when clinically appropriate after evaluation by a licensed clinician.

What to expect

Improvement typically builds over several weeks of regular use, and maintenance dosing continues long-term — GSM returns if treatment stops. For recurrent UTIs after menopause, vaginal estrogen is one of the best-evidenced preventive measures available, and we use it as part of a proper urinary workup, not instead of one.

Questions

Asked in almost every consult.

Is vaginal estrogen safe if I can't take systemic hormones?

Because absorption is minimal, low-dose vaginal estrogen is considered appropriate for many women who aren't candidates for systemic therapy — sometimes including women with a breast cancer history, in coordination with their oncologist. Your specific history drives the decision at consultation.

I'm on HRT. Why do I still have dryness?

Common and fixable: standard systemic doses don't always deliver enough estrogen to genitourinary tissue. Adding low-dose local treatment on top of systemic therapy is routine practice.

How is this different from the lubricants I've tried?

Lubricants reduce friction during sex; moisturizers ease day-to-day dryness. Both treat symptoms only. Vaginal estrogen restores the tissue itself — thickness, elasticity, blood flow, and pH — which is why it also helps urinary symptoms lubricants can't touch.

Do I have to use it forever?

For lasting benefit, yes — like glasses, it works while you use it. It's a maintenance therapy, reviewed at your regular follow-ups. Costs are on our pricing page; the medication itself often runs through your pharmacy benefit.

By appointment · Los Angeles & San Fernando Valley · California telehealth

Book a consultation.

Call or text and we'll find your slot. Online scheduling is coming soon.

Please keep health details out of text and email — save those for your visit. By texting us you consent to receive scheduling replies by SMS; reply STOP to opt out. If this is an emergency, call 911.